Cargando…

Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?

The aim of this study was to use 7 T ex vivo magnetic resonance imaging (MRI) scans to determine the size of lymph nodes (LNs) in total mesorectal excision (TME) specimens and to increase the pathological yield of LNs with MR-guided pathology. MATERIALS AND METHODS: Twenty-two fixated TME specimens...

Descripción completa

Detalles Bibliográficos
Autores principales: Stijns, Rutger, Philips, Bart, Wauters, Carla, de Wilt, Johannes, Nagtegaal, Iris, Scheenen, Tom
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738635/
https://www.ncbi.nlm.nih.gov/pubmed/31219996
http://dx.doi.org/10.1097/RLI.0000000000000581
_version_ 1783450846526177280
author Stijns, Rutger
Philips, Bart
Wauters, Carla
de Wilt, Johannes
Nagtegaal, Iris
Scheenen, Tom
author_facet Stijns, Rutger
Philips, Bart
Wauters, Carla
de Wilt, Johannes
Nagtegaal, Iris
Scheenen, Tom
author_sort Stijns, Rutger
collection PubMed
description The aim of this study was to use 7 T ex vivo magnetic resonance imaging (MRI) scans to determine the size of lymph nodes (LNs) in total mesorectal excision (TME) specimens and to increase the pathological yield of LNs with MR-guided pathology. MATERIALS AND METHODS: Twenty-two fixated TME specimens containing adenocarcinoma were scanned on a 7 T preclinical MRI system with a T1-weighted 3-dimensional gradient echo sequence with frequency-selective lipid excitation (repetition time/echo time, 15/3 milliseconds; resolution, 0.293 mm(3)) and a water-excited 3-dimensional multigradient echo (repetition time, 30 milliseconds; computed echo time, 6.2 milliseconds; resolution, 0.293 mm(3)) pulse sequence. The first series of 11 TME specimens (S1) revealed the number and size of LNs on both ex vivo MRI and histopathology. The second series of 11 TME specimens (S2) was used to perform MR-guided pathology. The number, size, and percentages of yielded LNs of S1 and S2 were compared. RESULTS: In all specimens (22/22), a median number of 34 LNs (interquartile range, 26–34) was revealed on ex vivo MRI compared with 14 LNs (interquartile range, 7.5–21.5) on histopathology (P = 0.003). Mean size of all LNs did not differ between the 2 series (ex vivo MRI: 2.4 vs 2.5 mm, P = 0.267; pathology: 3.6 vs 3.5 mm, P = 0.653). The median percentages of harvested LNs compared with nodes visible on ex vivo MRI per specimen for both series were not significantly different (40% vs 43%, P = 0.718). By using a size threshold of greater than 2 mm, the percentage improved to 71% (S1) and to 78% (S2, P = 0.895). The median number of harvested LNs per specimen did not increase by performing MR-guided pathology (S1, 14 LNs; S2, 20 LNs; P = 0.532). CONCLUSIONS: Ex vivo MRI visualizes more LNs than (MR-guided) pathology is able to harvest. Current pathological examination was not further improved by MR guidance. The majority of LNs or LN-like structures visible on ex vivo MRI below 2 mm in size remain unexplained, which warrants a 3-dimensional approach for pathological reconstruction of specimens.
format Online
Article
Text
id pubmed-6738635
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-67386352019-10-02 Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination? Stijns, Rutger Philips, Bart Wauters, Carla de Wilt, Johannes Nagtegaal, Iris Scheenen, Tom Invest Radiol Original Articles The aim of this study was to use 7 T ex vivo magnetic resonance imaging (MRI) scans to determine the size of lymph nodes (LNs) in total mesorectal excision (TME) specimens and to increase the pathological yield of LNs with MR-guided pathology. MATERIALS AND METHODS: Twenty-two fixated TME specimens containing adenocarcinoma were scanned on a 7 T preclinical MRI system with a T1-weighted 3-dimensional gradient echo sequence with frequency-selective lipid excitation (repetition time/echo time, 15/3 milliseconds; resolution, 0.293 mm(3)) and a water-excited 3-dimensional multigradient echo (repetition time, 30 milliseconds; computed echo time, 6.2 milliseconds; resolution, 0.293 mm(3)) pulse sequence. The first series of 11 TME specimens (S1) revealed the number and size of LNs on both ex vivo MRI and histopathology. The second series of 11 TME specimens (S2) was used to perform MR-guided pathology. The number, size, and percentages of yielded LNs of S1 and S2 were compared. RESULTS: In all specimens (22/22), a median number of 34 LNs (interquartile range, 26–34) was revealed on ex vivo MRI compared with 14 LNs (interquartile range, 7.5–21.5) on histopathology (P = 0.003). Mean size of all LNs did not differ between the 2 series (ex vivo MRI: 2.4 vs 2.5 mm, P = 0.267; pathology: 3.6 vs 3.5 mm, P = 0.653). The median percentages of harvested LNs compared with nodes visible on ex vivo MRI per specimen for both series were not significantly different (40% vs 43%, P = 0.718). By using a size threshold of greater than 2 mm, the percentage improved to 71% (S1) and to 78% (S2, P = 0.895). The median number of harvested LNs per specimen did not increase by performing MR-guided pathology (S1, 14 LNs; S2, 20 LNs; P = 0.532). CONCLUSIONS: Ex vivo MRI visualizes more LNs than (MR-guided) pathology is able to harvest. Current pathological examination was not further improved by MR guidance. The majority of LNs or LN-like structures visible on ex vivo MRI below 2 mm in size remain unexplained, which warrants a 3-dimensional approach for pathological reconstruction of specimens. Lippincott Williams & Wilkins 2019-10 2019-06-18 /pmc/articles/PMC6738635/ /pubmed/31219996 http://dx.doi.org/10.1097/RLI.0000000000000581 Text en Copyright © 2019 The Author(s). Published by Wolters Kluwer Health, Inc. This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (http://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal.
spellingShingle Original Articles
Stijns, Rutger
Philips, Bart
Wauters, Carla
de Wilt, Johannes
Nagtegaal, Iris
Scheenen, Tom
Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
title Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
title_full Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
title_fullStr Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
title_full_unstemmed Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
title_short Can Ex Vivo Magnetic Resonance Imaging of Rectal Cancer Specimens Improve the Mesorectal Lymph Node Yield for Pathological Examination?
title_sort can ex vivo magnetic resonance imaging of rectal cancer specimens improve the mesorectal lymph node yield for pathological examination?
topic Original Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6738635/
https://www.ncbi.nlm.nih.gov/pubmed/31219996
http://dx.doi.org/10.1097/RLI.0000000000000581
work_keys_str_mv AT stijnsrutger canexvivomagneticresonanceimagingofrectalcancerspecimensimprovethemesorectallymphnodeyieldforpathologicalexamination
AT philipsbart canexvivomagneticresonanceimagingofrectalcancerspecimensimprovethemesorectallymphnodeyieldforpathologicalexamination
AT wauterscarla canexvivomagneticresonanceimagingofrectalcancerspecimensimprovethemesorectallymphnodeyieldforpathologicalexamination
AT dewiltjohannes canexvivomagneticresonanceimagingofrectalcancerspecimensimprovethemesorectallymphnodeyieldforpathologicalexamination
AT nagtegaaliris canexvivomagneticresonanceimagingofrectalcancerspecimensimprovethemesorectallymphnodeyieldforpathologicalexamination
AT scheenentom canexvivomagneticresonanceimagingofrectalcancerspecimensimprovethemesorectallymphnodeyieldforpathologicalexamination